Spending on Orphan Cancer Drugs for Ultra-Rare, Rare, and Common Diseases
| Year of publication: |
[2023]
|
|---|---|
| Authors: | Michaeli, Daniel T. ; Michaeli, Thomas |
| Publisher: |
[S.l.] : SSRN |
| Subject: | Krebskrankheit | Cancer | Arzneimittel | Pharmaceuticals | Gesundheitskosten | Health care costs | Krankheit | Disease |
| Description of contents: |
This cross-sectional study compares Medicare & Medicaid spending on and beneficiaries of ultra-rare, rare, common, and non-orphan cancer drugs
|
freely available
| Extent: | 1 Online-Ressource (8 p) |
|---|---|
| Type of publication: | Book / Working Paper |
| Language: | English |
| Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments April 17, 2023 erstellt |
| Other identifiers: | 10.2139/ssrn.4421181 [DOI] |
| Classification: | I1 - Health ; I10 - Health. General ; i13 ; I18 - Government Policy; Regulation; Public Health |
| Source: | ECONIS - Online Catalogue of the ZBW |
Persistent link: https://www.econbiz.de/10014357841